A new paradigm in ulcerative colitis: Regulatory T cells are key factor which induces/exacerbates UC through an immune imbalance

被引:28
作者
Hanai, Hiroyuki [1 ]
Iida, Takayuki [1 ]
Ikeya, Kentaro [1 ]
Abe, Jinrou [1 ]
Maruyama, Yasuhiko [2 ]
Shimura, Teruyuki [2 ]
Sugimoto, Ken [3 ]
Watanabe, Fumitoshi [1 ]
机构
[1] Hamamatsu South Hosp, Ctr Gastroenterol & Inflammatory Bowel Dis Res, Hamamatsu, Shizuoka 430846, Japan
[2] Fujieda Municipal Hosp, Fujieda, Shizuoka, Japan
[3] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4312102, Japan
关键词
Ulcerative colitis; Leukocytapheresis; Regulatory T cell; Activated Treg cell; Resting Treg cell; Effector memory T cell; INFLAMMATORY-BOWEL-DISEASE; MONOCYTE ADSORPTION APHERESIS; LEUKOCYTAPHERESIS THERAPY; INTESTINAL INFLAMMATION; 5-AMINOSALICYLIC ACID; PATHOGENESIS; CYTOKINES; GRANULOCYTE; SUBSETS; MEMORY;
D O I
10.1016/j.molimm.2012.11.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Leukocytapheresis (LCAP) appears to remove or inactivate inflammatory cells and to reset immunological responses, resulting to cure responders of ulcerative colitis (UC). The changes of T cell subsets were investigated in UC patients treated with LCAP. Levels of T cell subsets in peripheral blood before and after LCAP were analysed by flow cytometric analysis. Of 20 UC patients, 13 (65%) achieved remission and 2 (10%) showed the improvement of UC symptoms. Ratios of some T cell subtypes such as regulatory T (Treg) cells and memory T cells to CD4(+) T cells changed significantly only in responders. Especially, ratio of resting Treg/CD4(+) T cells was significantly increased after the first LCAP session, and then one of activated Treg/CD4(+) T cells was increased after 2 week. This may lead to the development of a new UC paradigm in which an imbalance in Treg cell subsets triggers the onset and/or exacerbation of UC. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 54 条
[1]
Leukocytapheresis therapy modulates circulating T cell subsets in patients with ulcerative colitis [J].
Andoh, A ;
Tsujikawa, T ;
Inatomi, O ;
Deguchi, Y ;
Sasaki, M ;
Obata, H ;
Mitsuyama, K ;
Fujiyama, Y .
THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (03) :270-276
[2]
Suppression of interleukin-1β- and tumor necrosis factor-α-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis [J].
Andoh, A ;
Ogawa, A ;
Kitamura, K ;
Inatomi, O ;
Fujino, S ;
Tsujikawa, T ;
Sasaki, M ;
Mitsuyama, K ;
Fujiyama, Y .
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) :1150-1157
[3]
Immunopathogenesis of inflammatory bowel disease: current concepts [J].
Bamias, Giorgos ;
Cominelli, Fabio .
CURRENT OPINION IN GASTROENTEROLOGY, 2007, 23 (04) :365-369
[4]
Bettelli E., 2008, NATURE IMMUNOLOGY, V8, P345
[5]
Prospects for research in inflammatory bowel disease [J].
Blumberg, RS ;
Strober, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05) :643-647
[6]
Therapy with anti-TNFα Antibody Enhances Number and Function of Foxp3+ Regulatory T Cells in Inflammatory Bowel Diseases [J].
Boschetti, Gilles ;
Nancey, Stephane ;
Sardi, Fatima ;
Roblin, Xavier ;
Flourie, Bernard ;
Kaiserlian, Dominique .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) :160-170
[7]
Inflammatory Effects of Ex Vivo Human Th17 Cells Are Suppressed by Regulatory T Cells [J].
Crome, Sarah Q. ;
Clive, Breanna ;
Wang, Adele Y. ;
Kang, Christine Y. ;
Chow, Vickie ;
Yu, Jie ;
Lai, Amy ;
Ghahary, Aziz ;
Broady, Raewyn ;
Levings, Megan K. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (06) :3199-3208
[8]
Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease [J].
D'Odorico, A ;
D'Inca, R ;
Mestriner, C ;
Di Leo, V ;
Ferronato, A ;
Sturniolo, GC .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (08) :1594-1600
[9]
Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease [J].
Eastaff-Leung, Nicola ;
Mabarrack, Nicholas ;
Barbour, Angela ;
Cummins, Adrian ;
Barry, Simon .
JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (01) :80-89
[10]
Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes [J].
Evans, Hayley G. ;
Suddason, Tesha ;
Jackson, Ian ;
Taams, Leonie S. ;
Lord, Graham M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) :17034-17039